Selank for Anxiety: Exploring Its Calming and Cognitive Potential
A hopeful look at the human anxiety studies, the science behind Selank’s proposed effects, and the practical questions worth asking.

In this article
For people living with anxiety, the goal is often more than feeling less worried. It is being able to think clearly, stay engaged, and feel more like yourself. Selank is an interesting part of the conversation about new treatment possibilities. Looking closely at its research offers room for genuine curiosity and a more informed kind of hope.
What is Selank?
Selank is a synthetic peptide made from seven amino acids. It was developed from tuftsin, a naturally occurring peptide involved in immune signaling, and studied by Russian researchers for anxiety-related effects. A peptide is a short chain of amino acids; the category itself tells us neither that a treatment is safe nor that it should be dismissed.1
Human research has examined intranasal Selank. Its appeal lies in the possibility of easing anxiety while supporting, rather than dulling, everyday mental functioning.23
The encouraging findings in people
A 2008 study enrolled 62 people with generalized anxiety disorder or neurasthenia, a diagnosis associated with fatigue and related symptoms. Thirty received Selank and 32 received medazepam, a benzodiazepine. The authors reported similar anti-anxiety effects, with additional anti-fatigue and psychostimulant effects in the Selank group.2
In a 2014 comparison involving 60 patients with anxiety-related or somatoform disorders, researchers reported marked anxiety relief, mild nootropic effects, and improvements in quality of life with Selank. They also reported that the anti-anxiety effect continued for a week after the last administration.3
A 2015 study examined Selank added to phenazepam rather than Selank alone. Among 70 patients, the combination was associated with an earlier therapeutic effect and fewer reported phenazepam-related problems, including sedation and difficulties with attention or memory. That finding supports further study of Selank’s potential role alongside other care; it is not a reason to combine these substances yourself.4
These were small studies using active treatments as comparators, not large placebo-controlled confirmation trials. Their value is that they offer human signals worth pursuing—not just a theory from a laboratory.234
How might it influence anxiety?
One research thread involves GABA, a major inhibitory messenger in the nervous system. In a 2016 rat study, Selank changed the expression of genes involved in neurotransmission, with patterns overlapping those seen after GABA administration. The authors proposed modulation of GABA-related signaling as one possible mechanism.1
That gives researchers a useful direction to investigate: whether Selank can influence the systems involved in calming neural activity. It does not mean Selank acts exactly like a benzodiazepine or that the rat findings describe every effect in people.1
What about memory, focus, and BDNF?
The cognitive side of Selank is another reason it attracts attention. The 2014 human study reported mild nootropic effects, while the 2015 add-on study found fewer attention and memory problems with the combination treatment. Those are encouraging observations, although they do not establish a general memory boost for healthy people.34
Animal research adds another piece. In a 2019 rat study, Selank improved performance on a memory task and helped prevent memory and attention disturbances associated with prolonged ethanol exposure and withdrawal. The researchers also observed changes involving brain-derived neurotrophic factor, or BDNF, a protein involved in neuronal function.5
Importantly, the BDNF finding was about regulation in a specific animal model—not simply ‘more BDNF is better.’ It offers a research lead for understanding cognition, not a recommendation to use Selank for alcohol withdrawal.5
Why the potential is worth taking seriously
A treatment that could reduce anxiety while preserving alertness would address something many people care about: functioning well, not merely feeling sedated. The reported anxiety, fatigue, and cognitive findings make that a meaningful question for future Selank studies.234
The next useful studies would clarify how much benefit people experience, who benefits most, how long it lasts, and how it compares with established options. Larger studies with standardized preparations and longer follow-up could turn these early signals into more dependable treatment guidance.
Safety and product quality deserve a clear place in the discussion
Selank is not an FDA-approved anxiety treatment in the United States. FDA has identified potential immune-reaction risks with compounded Selank acetate for certain routes, related to aggregation and peptide impurities, and says important human safety information is missing.67
This is why promising study results should not be translated into claims that Selank has ‘no side effects,’ ‘no interactions,’ or no dependence risk. Small, short-term studies cannot settle those questions. A product sold online also should not be assumed to match the preparation used in a clinical paper.6
If Selank interests you, bring the studies to a qualified clinician or pharmacist. Ask about your current treatment, possible interactions, product quality, regulatory status, and whether a legitimate research setting is available. There is no universal self-use dosing plan established by the studies summarized here, and a research-only product is not an invitation to self-administer it.
A hopeful direction to keep following
Selank deserves a thoughtful look because researchers have reported encouraging anxiety findings in people and interesting leads in laboratory work. Its potential is more specific—and more useful—than sweeping promises about a ‘brain-enhancing’ peptide.12345
It is reasonable to be curious about where that research could lead. You can take emerging options seriously while keeping current care supported and making decisions with someone who understands your health history. Hope and careful judgment can work together.
Words worth knowing
Cognitive behavioral therapy (CBT)
A structured therapy that helps people notice patterns between thoughts, feelings, and actions, then practice more helpful responses.
References
- Volkova and colleagues (2016). Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Frontiers in Pharmacology. Rat study.
- Zozulia and colleagues (2008). Efficacy and possible mechanisms of action of Selank in generalized anxiety disorders and neurasthenia. Human comparison study; English abstract.
- Medvedev and colleagues (2014). A comparison of the anxiolytic effect and tolerability of Selank and phenazepam in anxiety disorders. Human study; English abstract.
- Medvedev and colleagues (2015). Optimization of the treatment of anxiety disorders with Selank. Human add-on study; English abstract.
- Kolik and colleagues (2019). Selank protects against ethanol-induced memory impairment and regulates BDNF content in rats. Bulletin of Experimental Biology and Medicine.
- U.S. Food and Drug Administration. Certain bulk drug substances that may present significant safety risks: Selank acetate (TP-7).
- U.S. Food and Drug Administration (2020). Tailor Made Compounding warning letter: Selank and FDA-approved human drug status.
